Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL457988 | 0.96 | — | — | |
| SCHEMBL28873827 | 0.92 | — | — | |
| Bicarbonate SCHEMBL28680773 | 0.88 | — | — | |
| Bicarbonate SCHEMBL28680770 | 0.88 | ALDH1A1 (0.44) | — | |
| Formaldehyde SCHEMBL10946288 | 0.88 | — | — | |
| Thiocyanic Acid SCHEMBL27517955 | 0.77 | — | — | |
| Piperazine SCHEMBL27891030 | 0.77 | MAPT (0.35) | — | |
| Nitric Acid SCHEMBL31562143 | 0.77 | — | — | |
| E927A SCHEMBL28171740 | 0.70 | — | — | |
| SCHEMBL17075219 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3115394-B1 | ANTIVIRAL AGENT | ASHKINAZI RIMMA ILIINICHNA (RU) | 2022-03-30 | — | — | EP | claimed |
| CN-117364531-A | Antibacterial paper towel and preparation method thereof | 安徽创意家生物科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| EP-3115394-B1 | ANTIVIRAL AGENT | ASHKINAZI RIMMA ILIINICHNA (RU) | 2022-03-30 | — | — | EP | disclosed |
| CN-107868023-B | Biguanide phosphate synthesis method and antibacterial agent | 中国石油化学工业开发股份有限公司 | 2020-05-08 | — | — | CN | disclosed |
| US-10299480-B2 | Antiviral agent | VIKTOR VENIAMINOVICH TETS (RU) | 2019-05-28 | — | — | US | disclosed |
| US-20170013838-A1 | ANTIVIRAL AGENT | TETS, GEORGY VIKTOROVICH (RU) | 2017-01-19 | — | — | US | disclosed |
| EP-3115394-A1 | ANTIVIRAL AGENT | Ashkinazi, Rimma Iliinichna (RU) | 2017-01-11 | — | — | EP | disclosed |
| CN-104782651-A | Compositing and compounding process for bactericide for oilfield wastewater reinjection treatment | DONGYING DONGFANG CHEMICAL INDUSTRY CO LTD | 2015-07-22 | — | — | CN | disclosed |
| US-7521479-B2 | Methods of treating prion disease in mammals | PANACEA PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| WO-2002083116-A1 | METHODS OF TREATING PRION DISEASE IN MAMMALS COMPRISING ADMINISTERING A CHAOTROPIC AGENT SUCH AS GUANIDINE, UREA OR POTASSIUM IODIDE | PANACEA PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| US-20020150631-A1 | Methods of treating prion disease in mammals | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE | 2002-10-17 | — | — | US | disclosed |
| EP-0404590-A2 | Method of and reagent for the prevention of turbidity | TECHNICON GMBH (DE) | 1990-12-27 | — | — | EP | disclosed |
| US-4507250-A | OXIDATION, SALT FORMATION | GESHURI LABORATORIES LTD. (IL) | 1985-03-26 | — | — | US | disclosed |
| EP-0125363-A1 | Process for producing N-phosphonomethylglycine acid | Geshuri Laboratories Ltd. (IL) | 1984-11-21 | — | — | EP | disclosed |
| US-4311618-A | Cleanser with ionic and nonionic surfactants | SCHAEFER BURKHARD WERNER | 1982-01-19 | — | — | US | disclosed |